查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553963

靜脈曲張治療市場規模、佔有率和趨勢分析報告：按類型、最終用途、地區和細分市場預測，2024-2030 年

Varicose Veins Treatment Market Size, Share & Trends Analysis Report By Type (Endovenous Ablation, Injection Sclerotherapy), By End-use (Specialty Clinics, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

靜脈曲張治療市場的成長與趨勢：

Grand View Research I am 的最新報告顯示，到 2030 年，全球靜脈曲張治療市場規模預計將達到 20.8 億美元，2024 年至 2030 年複合年成長率預計為 6.4%。

技術進步的不斷進步，加上先進靜脈曲張治療設備的可用性增加以及向微創手術的轉變是推動市場成長的因素。

歐洲和北美血管疾病的高負擔、患者依從性和信心的提高、醫療保健支出的增加以及老年人口的迅速增加是靜脈曲張治療市場的主要驅動力。

肥胖、睡眠障礙、血壓水平升高、荷爾蒙變化、遺傳性疾病以及妊娠等文明病的盛行率增加是導致周邊血管疾病的一些主要因素。未經治療的靜脈功能不全，例如靜脈曲張和靜脈潰瘍，會導致進行進行性症候群，包括慢性靜脈功能不全。 2015 年，根據 FutSci 報導，慢性靜脈功能不全是一種廣泛存在的社會孤立性疾病，會導致成年人患病。它是世界上最常見的疾病，估計影響西方國家 5% 的人口。

靜脈曲張治療市場報告亮點：

  • 硬化療法因其切口小、疤痕少等優點而被公認為最盈利的治療方法。此外，諸如增加滲透性、成本和時間效率、降低周圍組織附帶損傷的風險、減少術後併發症以及無痛手術等優點也促進了該細分市場的成長。
  • 靜脈消融治療領域因其治療時間短、術後血液循環改善等優點預計將成為成長最快的領域。由於副作用最小化、潛在的成本節省和更好的患者治療效果，ClosureFast 技術在靜脈消融治療領域的發展勢頭越來越強勁。
  • 靜脈化學消融或化學硬化療法是消融療法中使用最廣泛的醫療程序。硬化療法、強烈脈衝光療法、雷射消熔、射頻和門診靜脈曲張切除術是較新的技術，由於侵入性較小，因此使用更頻繁。
  • 由於該地區人口中靜脈曲張和蜘蛛網狀靜脈曲張的盛行率不斷上升、有利的報銷政策、醫療保健意識的提高、政府支出以及美容意識的提高，到 2023 年，北美將佔據最大的市場佔有率。
  • 由於醫療基礎設施改善、患者對靜脈曲張早期治療益處的意識層級不斷提高以及可支配收入增加等因素，亞太地區預計將出現最快的成長。
  • 市場主要企業包括 Quanta Systems SpA、Vascular Solutions, Inc.、Eufoton SRL、Energist Group、Medtronic plc、Dornier MedTech GmbH、Lumenis Ltd.、Syneron Medical Ltd.、Biolitec AG、AngioDynamics, Inc.。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章靜脈曲張治療市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 靜脈曲張治療市場分析工具
    • 波特的分析
    • PESTEL分析

第4章下肢靜脈曲張治療市場：按類型估計和趨勢分析

  • 細分儀表板
  • 靜脈曲張治療市場：類型變化分析，2023 年和 2030 年
  • 靜脈內消融（EVLA）
  • 注射硬化療法
  • 手術結紮/剝離

第5章下肢靜脈曲張治療市場：依最終用途分類的估計與趨勢分析

  • 細分儀表板
  • 靜脈曲張治療市場：2023 年和 2030 年最終用途變化分析
  • 醫院
  • 門診手術中心
  • 專科診所

第6章 下肢靜脈曲張治療市場：區域估計與趨勢分析

  • 2023 年及 2030 年靜脈曲張治療市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Medtronic
    • Lumenis Be Ltd.
    • AngioDynamics
    • Sciton
    • Quanta System
    • intros Medical Laser GmbH
    • Alma lasers
    • Dornier MedTech
    • Theraclion
簡介目錄
Product Code: 978-1-68038-963-0

Varicose Veins Treatment Market Growth & Trends:

The global varicose veins treatment market size is expected to reach USD 2.08 billion by 2030, registering to grow at a CAGR of 6.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. The increasing technological advancements coupled with the increased availability of the advanced varicose vein treatment devices and shift towards less-invasive procedures are the contributing factors for the growth of the market.

The huge burden of vascular diseases in Europe and North America and the increasing patient compliance and reliability, growth in healthcare expenditure, and the rapid growth in geriatric population is majorly driving the varicose vein procedure market.

The upward trend in lifestyle disorders, such as increasing obesity, sleep disorders, blood pressure levels, hormonal changes, genetic disorders and pregnancy are the few major factors contributing to the peripheral vascular diseases. Untreated venous insufficiency, such as varicose vein and venous ulcers cause progressive syndromes including chronic veinous insufficiency. In 2015, according to FutSci, chronic veinous insufficiency is widespread and is a socially isolating condition caused in adults. It is the most common disease in the world and is estimated to affect 5% of the population in the Western countries.

Varicose Veins Treatment Market Report Highlights:

  • The sclerotherapy segment was identified as the most profitable procedure owing to the benefits, such as the requirement of minimal incision and reduced scarring, related to the procedure. Moreover,the following advantages: increased penetration, cost and time efficiency, reduced risk of collateral damage to surrounding tissues, fewer post-operative complications, and painless procedure are the main contributors for the growth of this segment.
  • The endovenous ablation segment is expected to be the fastest growing segment due to the benefits of short treatment time and improved blood circulation after the procedure. The ClosureFast technique in the endovenous ablation treatment segment has gained momentum due to the minimized side effects, potential cost-saving ability, and better patient outcomes.
  • The endovenous chemoablation or chemical sclerosis segment was the most widely used medical procedure among the ablation procedures. Sclerotherapy, intense-pulsed-light therapy, laser ablation, radiofrequency, and ambulatory phlebectomy are the modern techniques that are usedmore oftendue to their less invasive nature.
  • In 2023, North America held the largest market share due to the increasing incidence rate of varicose and spider vein in the population, favourable reimbursement policies, increased healthcare awareness, government spending, and the rising aesthetic awareness in the region
  • The Asia Pacific is expected to register the fastest growth due to factors, such as the improving healthcare infrastructure, the increase in patient awareness level regarding the benefits of early treatment of the varicose veins, and the rising disposable income
  • Some key players of the market include Quanta Systems S.p.A, Vascular Solutions, Inc., Eufoton S.R.L, Energist Group, Medtronic plc, Dornier MedTech GmbH, Lumenis Ltd., Syneron Medical Ltd., Biolitec AG, and AngioDynamics, Inc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Varicose Veins Treatment Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Varicose Veins Treatment Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Varicose Veins Treatment Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Varicose Veins Treatment Market: Type Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Endovenous Ablation (EVLA)
    • 4.3.1. Endovenous Ablation (EVLA) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Radiofrequency Ablation
      • 4.3.2.1. Radiofrequency Ablation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Laser Ablation
      • 4.3.3.1. Laser Ablation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Injection Sclerotherapy
    • 4.4.1. Injection Sclerotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Surgical Ligation/Stripping
    • 4.5.1. Surgical Ligation/Stripping Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Varicose Veins Treatment Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Varicose Veins Treatment Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Ambulatory Surgical Centers
    • 5.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Specialty Clinics
    • 5.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Varicose Veins Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Varicose Veins Treatment Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Thailand Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. South Korea Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Varicose Veins Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Medtronic
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Lumenis Be Ltd.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. AngioDynamics
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Sciton
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Quanta System
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. intros Medical Laser GmbH
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Alma lasers
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Dornier MedTech
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Theraclion
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives